FUJIFILM Diosynth is delighted to be a Thought Leader Partner at American Biomanufacturing Summit, April 10-11, 2024 in San Francisco, CA. Stop by booth #45 to meet with our team to learn more about FUJIFILM Diosynth Biotechnologies’ capabilities and how we can help you advance and deliver tomorrow’s medicines.

Join us at 12:05 PM – Day 1 Workshop, Room 4

Sara Miller, Associate Director, Cell Therapy Business at FUJFILM Diosynth Biotechnologies will be speaking on AN ALLOGENEIC COMMERCIAL JOURNEY

  • Discussing the path of preparing a GMP cell therapy manufacturing facility to become a full service commercial CDMO
  • Focusing on the journey taken to support the first approval of an allogeneic T cell immunotherapy from inception through its PAI inspections and commercial approval as well as advancing other cell therapy programs
  • Introducing pre-IND programs to devising flexible systems to support programs at all phases to the acquisition by FUJIFILM Diosynth Biotechnologies
  • Allogeneic cell therapy as the next breakthrough in making cell therapy available to larger groups of patients who need it